The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites.
Identifieur interne : 002E24 ( PubMed/Corpus ); précédent : 002E23; suivant : 002E25The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites.
Auteurs : V. Ruocco ; G. Brunetti ; R V Puca ; E. RuoccoSource :
- Journal of the European Academy of Dermatology and Venereology : JEADV [ 1468-3083 ] ; 2009.
English descriptors
- KwdEn :
- MESH :
- complications : Herpesviridae Infections.
- etiology : Lymphedema.
- pathology : Herpesviridae Infections, Lymphedema.
- Chronic Disease, Humans, Immunocompromised Host.
Abstract
Systemic immunodeficiency is known to facilitate the onset of opportunistic infections, tumours and immune disorders in any district of the body. There are clinical events, such as chronic lymphoedema, herpetic infections, vaccinations and heterogeneous physical injuries which can selectively damage and immunologically mark the cutaneous district they act upon. After the causing event has disappeared, the affected district may appear clinically normal, but its immune behaviour is often compromised forever. An immunocompromised district becomes a site which is particularly susceptible to subsequent outbreaks of opportunistic infections, tumours and immune disorders confined to the district itself. In this review, there is an ample case-report collection of opportunistic disorders (infectious, neoplastic, immune) which appeared in immunocompromised districts. The cases have been grouped according to the clinical settings responsible for the local immune imbalance: regional chronic lymphoedema; herpes-infected sites, which feature the well-known Wolf's isotopic response; and otherwise damaged areas, comprising sites of vaccination, ionizing or UV radiation, thermal burns and traumas. Whatever the immunocompromising factor, a common denominator which facilitates the occurrence of tumours, infections and dysimmune reactions in an immunocompromised district may reside in locally hampered lymph drainage and/or locally altered neuromediator signalling. In fact, any obstacle to the normal trafficking of immunocompetent cells through lymphatic channels or any interference with the signals that the neuropeptides and neurotransmitters released by peripheral nerves send to cell membrane receptors of immunocompetent cells, can significantly alter the local immune response, thus paving the way for heterogeneous opportunistic disorders in the immunocompromised district.
DOI: 10.1111/j.1468-3083.2009.03345.x
PubMed: 19548975
Links to Exploration step
pubmed:19548975Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites.</title>
<author><name sortKey="Ruocco, V" sort="Ruocco, V" uniqKey="Ruocco V" first="V" last="Ruocco">V. Ruocco</name>
<affiliation><nlm:affiliation>Department of Dermatology, 2nd University of Naples, Naples, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Brunetti, G" sort="Brunetti, G" uniqKey="Brunetti G" first="G" last="Brunetti">G. Brunetti</name>
</author>
<author><name sortKey="Puca, R V" sort="Puca, R V" uniqKey="Puca R" first="R V" last="Puca">R V Puca</name>
</author>
<author><name sortKey="Ruocco, E" sort="Ruocco, E" uniqKey="Ruocco E" first="E" last="Ruocco">E. Ruocco</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19548975</idno>
<idno type="pmid">19548975</idno>
<idno type="doi">10.1111/j.1468-3083.2009.03345.x</idno>
<idno type="wicri:Area/PubMed/Corpus">002E24</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002E24</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites.</title>
<author><name sortKey="Ruocco, V" sort="Ruocco, V" uniqKey="Ruocco V" first="V" last="Ruocco">V. Ruocco</name>
<affiliation><nlm:affiliation>Department of Dermatology, 2nd University of Naples, Naples, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Brunetti, G" sort="Brunetti, G" uniqKey="Brunetti G" first="G" last="Brunetti">G. Brunetti</name>
</author>
<author><name sortKey="Puca, R V" sort="Puca, R V" uniqKey="Puca R" first="R V" last="Puca">R V Puca</name>
</author>
<author><name sortKey="Ruocco, E" sort="Ruocco, E" uniqKey="Ruocco E" first="E" last="Ruocco">E. Ruocco</name>
</author>
</analytic>
<series><title level="j">Journal of the European Academy of Dermatology and Venereology : JEADV</title>
<idno type="eISSN">1468-3083</idno>
<imprint><date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chronic Disease</term>
<term>Herpesviridae Infections (complications)</term>
<term>Herpesviridae Infections (pathology)</term>
<term>Humans</term>
<term>Immunocompromised Host</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (pathology)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Herpesviridae Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Herpesviridae Infections</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Chronic Disease</term>
<term>Humans</term>
<term>Immunocompromised Host</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Systemic immunodeficiency is known to facilitate the onset of opportunistic infections, tumours and immune disorders in any district of the body. There are clinical events, such as chronic lymphoedema, herpetic infections, vaccinations and heterogeneous physical injuries which can selectively damage and immunologically mark the cutaneous district they act upon. After the causing event has disappeared, the affected district may appear clinically normal, but its immune behaviour is often compromised forever. An immunocompromised district becomes a site which is particularly susceptible to subsequent outbreaks of opportunistic infections, tumours and immune disorders confined to the district itself. In this review, there is an ample case-report collection of opportunistic disorders (infectious, neoplastic, immune) which appeared in immunocompromised districts. The cases have been grouped according to the clinical settings responsible for the local immune imbalance: regional chronic lymphoedema; herpes-infected sites, which feature the well-known Wolf's isotopic response; and otherwise damaged areas, comprising sites of vaccination, ionizing or UV radiation, thermal burns and traumas. Whatever the immunocompromising factor, a common denominator which facilitates the occurrence of tumours, infections and dysimmune reactions in an immunocompromised district may reside in locally hampered lymph drainage and/or locally altered neuromediator signalling. In fact, any obstacle to the normal trafficking of immunocompetent cells through lymphatic channels or any interference with the signals that the neuropeptides and neurotransmitters released by peripheral nerves send to cell membrane receptors of immunocompetent cells, can significantly alter the local immune response, thus paving the way for heterogeneous opportunistic disorders in the immunocompromised district.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19548975</PMID>
<DateCreated><Year>2010</Year>
<Month>02</Month>
<Day>23</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>06</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised><Year>2010</Year>
<Month>02</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-3083</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>23</Volume>
<Issue>12</Issue>
<PubDate><Year>2009</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of the European Academy of Dermatology and Venereology : JEADV</Title>
<ISOAbbreviation>J Eur Acad Dermatol Venereol</ISOAbbreviation>
</Journal>
<ArticleTitle>The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites.</ArticleTitle>
<Pagination><MedlinePgn>1364-73</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1468-3083.2009.03345.x</ELocationID>
<Abstract><AbstractText>Systemic immunodeficiency is known to facilitate the onset of opportunistic infections, tumours and immune disorders in any district of the body. There are clinical events, such as chronic lymphoedema, herpetic infections, vaccinations and heterogeneous physical injuries which can selectively damage and immunologically mark the cutaneous district they act upon. After the causing event has disappeared, the affected district may appear clinically normal, but its immune behaviour is often compromised forever. An immunocompromised district becomes a site which is particularly susceptible to subsequent outbreaks of opportunistic infections, tumours and immune disorders confined to the district itself. In this review, there is an ample case-report collection of opportunistic disorders (infectious, neoplastic, immune) which appeared in immunocompromised districts. The cases have been grouped according to the clinical settings responsible for the local immune imbalance: regional chronic lymphoedema; herpes-infected sites, which feature the well-known Wolf's isotopic response; and otherwise damaged areas, comprising sites of vaccination, ionizing or UV radiation, thermal burns and traumas. Whatever the immunocompromising factor, a common denominator which facilitates the occurrence of tumours, infections and dysimmune reactions in an immunocompromised district may reside in locally hampered lymph drainage and/or locally altered neuromediator signalling. In fact, any obstacle to the normal trafficking of immunocompetent cells through lymphatic channels or any interference with the signals that the neuropeptides and neurotransmitters released by peripheral nerves send to cell membrane receptors of immunocompetent cells, can significantly alter the local immune response, thus paving the way for heterogeneous opportunistic disorders in the immunocompromised district.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ruocco</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
<AffiliationInfo><Affiliation>Department of Dermatology, 2nd University of Naples, Naples, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Brunetti</LastName>
<ForeName>G</ForeName>
<Initials>G</Initials>
</Author>
<Author ValidYN="Y"><LastName>Puca</LastName>
<ForeName>R V</ForeName>
<Initials>RV</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ruocco</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2009</Year>
<Month>06</Month>
<Day>22</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Eur Acad Dermatol Venereol</MedlineTA>
<NlmUniqueID>9216037</NlmUniqueID>
<ISSNLinking>0926-9959</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006566" MajorTopicYN="N">Herpesviridae Infections</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016867" MajorTopicYN="Y">Immunocompromised Host</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>100</NumberOfReferences>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>6</Month>
<Day>25</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>6</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19548975</ArticleId>
<ArticleId IdType="pii">JDV3345</ArticleId>
<ArticleId IdType="doi">10.1111/j.1468-3083.2009.03345.x</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002E24 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002E24 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:19548975 |texte= The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:19548975" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |